What is the current Treatment for Gastroparesis market size?

The Treatment for Gastroparesis market size is approximately USD 4.8 billion as of 2022.

What is the expected growth forecast for the Treatment for Gastroparesis market?

The market is expected to grow at a CAGR of 7.2% from 2023 to 2028.

What are the key drivers of the Treatment for Gastroparesis market?

Increasing prevalence of diabetes and rising awareness of gastroparesis treatment options are key drivers.

What are the major challenges facing the Treatment for Gastroparesis market?

Lack of standard treatment guidelines and high treatment costs are significant challenges.

Which regions are expected to lead the Treatment for Gastroparesis market?

North America and Europe are expected to dominate the market due to high healthcare expenditure.

Who are the top companies in the Treatment for Gastroparesis market?

Major players include Abbott Laboratories, Boston Scientific, and Medtronic plc.

What future opportunities exist in the Treatment for Gastroparesis market?

Emerging markets and development of non-invasive treatments present significant opportunities.

How will technology impact the Treatment for Gastroparesis market?

Advances in diagnostic technologies and development of novel therapies will drive market growth.

What is the current regulatory landscape for the Treatment for Gastroparesis market?

Stringent regulatory approvals and reimbursement policies influence market dynamics.

What is the future outlook for the Treatment for Gastroparesis market?

The future outlook is positive, driven by increasing demand for effective treatments.

Which Companies Lead the Treatment for Gastroparesis Market in 2026?

Treatment for Gastroparesis by Application (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), by Types (Drugs, Surgical Treatment Products), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Treatment for Gastroparesis Market Overview

The Treatment for Gastroparesis market refers to the industry dedicated to providing medical solutions for gastroparesis, a condition characterized by delayed stomach emptying. As the Treatment for Gastroparesis market size is expected to reach $7.24 billion by 2026, the growth outlook and market forecast indicate a significant expansion, driven by increasing prevalence of gastroparesis and rising demand for effective treatments. The industry expansion is anticipated to be fueled by advancements in medical technology, changes in regulatory frameworks, and shifting consumer behavior, with key forces shaping the industry including technology shifts, regulations, and competitive intensity. The largest region in the Treatment for Gastroparesis market is North America, while the fastest-growing region is expected to be Asia-Pacific.

Loading chart…

The Treatment for Gastroparesis market is expected to grow at a CAGR of 7.5% during the forecast period, driven by the increasing prevalence of gastroparesis and the rising demand for effective treatments. The market is characterized by a competitive landscape, with key players investing heavily in research and development to introduce innovative treatments. As the market continues to evolve, it is likely to be shaped by factors such as consumer behavior, supply-chain dynamics, and regulatory frameworks, ultimately leading to increased market size and industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Janssen Global Services; Evoke Pharma; Cardinal Health; Salix Pharmaceuticals; Alfa Wassermann; Abbott Laboratories; Medtronic; C.R.Bard; Rhythm Pharmaceuticals; Boston Scientific; Kimberly-Clark
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Treatment for Gastroparesis market is experiencing significant transformations, driven by various factors that are reshaping its landscape. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing prevalence of gastroparesis due to rising diabetes and obesity rates is driving demand for effective treatments, thereby contributing to the growth of the Treatment for Gastroparesis market size.

Advancements in medical technology, including the development of novel drug delivery systems and minimally invasive procedures, are expanding the range of available treatment options and improving patient outcomes, which is expected to boost the growth forecast of the market.

Restraints2 items

High development costs and stringent regulatory requirements for new treatments are significant barriers to entry for pharmaceutical and medical device companies, potentially limiting the Treatment for Gastroparesis market size.

The lack of awareness about gastroparesis among patients and healthcare providers can lead to underdiagnosis and undertreatment, hindering the growth of the market and affecting the overall growth forecast.

Opportunities2 items

The growing demand for personalized medicine and targeted therapies presents opportunities for companies to develop innovative, patient-centric treatments that can improve outcomes and enhance the Treatment for Gastroparesis market.

Partnerships and collaborations between pharmaceutical companies, research institutions, and healthcare providers can facilitate the development of new treatments and accelerate the growth forecast of the market.

Challenges2 items

The complex pathophysiology of gastroparesis and the limited understanding of its underlying mechanisms pose significant challenges for the development of effective treatments, affecting the Treatment for Gastroparesis market size.

Ensuring patient access to affordable and effective treatments, particularly in resource-constrained settings, remains a major challenge that must be addressed to achieve sustainable growth in the Treatment for Gastroparesis market and improve the overall growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Treatment for Gastroparesis market refers to the various uses of treatments for gastroparesis, including diabetic gastroparesis, idopathic gastroparesis, and post-surgical gastroparesis. This segmentation is crucial in understanding the Treatment for Gastroparesis market size, as it helps identify the most significant application areas driving the market growth. The Treatment for Gastroparesis segmentation by application provides valuable insights into the market taxonomy, enabling stakeholders to develop targeted strategies.

The Types segment of the Treatment for Gastroparesis market encompasses various subtypes, including [object Object] and [object Object]. These subtypes contribute to the overall market size, with each having a distinct impact on the growth trajectory. Analyzing these subtypes is essential for understanding the market dynamics, as they cater to different patient needs and preferences. By examining the Treatment for Gastroparesis market taxonomy, researchers can identify areas of opportunity and challenge, ultimately informing business decisions.

Treatment for Gastroparesis Segmentation Breakdown9 items

Application

Hospital Pharmacies

Private Clinics

Drug Stores

Retail Pharmacies

E-Commerce

Types

Drugs

Surgical Treatment Products

Regional Insights

Loading chart…

The Treatment for Gastroparesis market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced treatments and growing infrastructure. Key drivers in North America include investments in research and development, policies supporting healthcare infrastructure, and a mature ecosystem. In Europe, drivers include demographics with an aging population, adoption of minimally invasive procedures, and policies promoting healthcare accessibility.

In Asia Pacific, key drivers include investments in healthcare infrastructure, demographics with a large and growing population, and increasing adoption of innovative treatments. Latin America's growth is driven by policies supporting healthcare development, infrastructure expansion, and growing ecosystem maturity. The Middle East & Africa region is expected to be driven by investments in healthcare, demographics with a young and growing population, and increasing adoption of advanced treatments, contributing to the regional forecast.

Competitive Landscape

The Treatment for Gastroparesis market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, and regulatory approvals. The Treatment for Gastroparesis competitive landscape is characterized by key competitive levers, including product differentiation, channel strength, and cost advantages. Global players tend to dominate the market, but local companies are also gaining traction through strategic partnerships and regional expansion.

Companies in the Treatment for Gastroparesis market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies focus on technology, service model, and channel strength to differentiate themselves. The following companies have adopted distinct strategic focuses:

Janssen Global Services: regional expansion

Evoke Pharma: innovation pipeline

Cardinal Health: vertical integration

Salix Pharmaceuticals: premium pricing

Alfa Wassermann: local manufacturing

Abbott Laboratories: OEM tie-ups

Key Treatment for Gastroparesis Companies11 items

Janssen Global Services

Evoke Pharma

Cardinal Health

Salix Pharmaceuticals

Alfa Wassermann

Abbott Laboratories

Medtronic

C.R.Bard

Rhythm Pharmaceuticals

Boston Scientific

Kimberly-Clark

Market Ecosystem

The Treatment for Gastroparesis ecosystem encompasses a complex network of participants, from upstream technology providers to downstream end users, with value created and captured at each stage. The ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream, with technology providers, integrators, and channels playing critical roles in the value chain analysis.

Raw material/component suppliers — providing medical equipment

OEMs / manufacturers — producing treatment devices

Technology providers — developing diagnostic tools

System integrators / EPCs — integrating treatment systems

Distributors / channel partners — supplying treatment products

Service providers / after-sales — offering maintenance services

End users / buyers — receiving treatment for Gastroparesis

In the Treatment for Gastroparesis ecosystem, control points are primarily held by regulatory bodies and technology providers, influencing adoption through standards and approvals. Dependency risks arise from input constraints, such as the availability of raw materials, and switching costs are high due to the specialized nature of treatment devices. Partnerships and interoperability requirements between system integrators and technology providers are crucial, and the ecosystem differs by region due to varying regulatory frameworks and healthcare infrastructure.

Recent Industry Insights

The Treatment for Gastroparesis industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been forged to enhance research and development of novel therapies, while mergers and acquisitions have led to consolidation and expansion of product portfolios. Notably, several product launches have taken place, including innovative drug delivery systems and medical devices designed to improve treatment outcomes for patients with gastroparesis.

Additionally, regulatory changes have paved the way for the approval of new treatments, and a shift in consumer trends has led to increased demand for minimally invasive and personalized therapeutic options. Funding rounds and expansions have also been announced, further fueling innovation and growth in the Treatment for Gastroparesis market. These developments are expected to drive the industry forward, shaping the future of gastroparesis treatment.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Treatment for Gastroparesis market. The market attractiveness is moderate, driven by the increasing prevalence of gastroparesis and the lack of effective treatments. The competitive intensity is high, with several pharmaceutical companies investing in research and development to address this unmet medical need. The long-term outlook for the Treatment for Gastroparesis market outlook is promising, with the potential for innovative therapies to improve treatment options and patient outcomes.

The innovation landscape is evolving, with a focus on novel pharmacological and device-based therapies. However, the demand–supply balance is a concern, as the current treatment options are often ineffective, leading to a significant unmet need. Key risk factors include regulatory challenges, reimbursement issues, and the potential for side effects associated with new treatments. Overall, the Treatment for Gastroparesis market requires careful navigation to capitalize on opportunities and mitigate risks.

11 items

1. Executive Summary

2. Treatment for Gastroparesis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Treatment for Gastroparesis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Treatment for Gastroparesis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital Pharmacies

6.1.2. Private Clinics

6.1.3. Drug Stores

6.1.4. Retail Pharmacies

6.1.5. E-Commerce

6.2. Global Treatment for Gastroparesis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Drugs

6.2.2. Surgical Treatment Products

6.3. Global Treatment for Gastroparesis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Treatment for Gastroparesis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Treatment for Gastroparesis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Treatment for Gastroparesis Market Competition by Key Manufacturers

8.1. Global Treatment for Gastroparesis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Treatment for Gastroparesis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Janssen Global Services

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Evoke Pharma

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardinal Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Salix Pharmaceuticals

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Alfa Wassermann

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Medtronic

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. C.R.Bard

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Rhythm Pharmaceuticals

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Boston Scientific

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kimberly-Clark

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Treatment for Gastroparesis Market

Figure 4: Global Treatment for Gastroparesis Market: Drivers

Figure 5: Global Treatment for Gastroparesis Market: Challenges

Figure 6: Global Treatment for Gastroparesis Market: Trends

Figure 7: Global Treatment for Gastroparesis Market: Opportunity

Figure 8: Global Treatment for Gastroparesis Market: Restraint

Figure 9: Global Treatment for Gastroparesis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Treatment for Gastroparesis Market Value (USD Million) By Region

Figure 15: Global Treatment for Gastroparesis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Treatment for Gastroparesis Market Value (USD Million) By Region

Figure 23: Global Treatment for Gastroparesis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Treatment for Gastroparesis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Treatment for Gastroparesis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Treatment for Gastroparesis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Treatment for Gastroparesis Market Value (USD Million) By Region

Table 10: Global Treatment for Gastroparesis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Treatment for Gastroparesis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Treatment for Gastroparesis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Treatment for Gastroparesis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Janssen Global Services Basic Information And Sales Area

Table 31: Janssen Global Services. Products Portfolio

Table 32: Evoke Pharma Basic Information And Sales Area

Table 33: Evoke Pharma. Products Portfolio

Table 34: Cardinal Health Basic Information And Sales Area

Table 35: Cardinal Health. Products Portfolio

Table 36: Salix Pharmaceuticals Basic Information And Sales Area

Table 37: Salix Pharmaceuticals. Products Portfolio

Table 38: Alfa Wassermann Basic Information And Sales Area

Table 39: Alfa Wassermann. Products Portfolio

Table 40: Abbott Laboratories Basic Information And Sales Area

Table 41: Abbott Laboratories. Products Portfolio

Table 42: Medtronic Basic Information And Sales Area

Table 43: Medtronic. Products Portfolio

Table 44: C.R.Bard Basic Information And Sales Area

Table 45: C.R.Bard. Products Portfolio

Table 46: Rhythm Pharmaceuticals Basic Information And Sales Area

Table 47: Rhythm Pharmaceuticals. Products Portfolio

Table 48: Boston Scientific Basic Information And Sales Area

Table 49: Boston Scientific. Products Portfolio

Table 50: Kimberly-Clark Basic Information And Sales Area

Table 51: Kimberly-Clark. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Treatment for Gastroparesis Market Value (USD Million) By Region

Table 57: Global Treatment for Gastroparesis Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Treatment for Gastroparesis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Janssen Global Services; Evoke Pharma; Cardinal Health; Salix Pharmaceuticals; Alfa Wassermann; Abbott Laboratories; Medtronic; C.R.Bard; Rhythm Pharmaceuticals; Boston Scientific; Kimberly-Clark
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Treatment for Gastroparesis Segmentation Breakdown9 items

Application

Hospital Pharmacies

Private Clinics

Drug Stores

Retail Pharmacies

E-Commerce

Types

Drugs

Surgical Treatment Products

Regional Insights

Loading chart…

Competitive Landscape

Janssen Global Services: regional expansion

Evoke Pharma: innovation pipeline

Cardinal Health: vertical integration

Salix Pharmaceuticals: premium pricing

Alfa Wassermann: local manufacturing

Abbott Laboratories: OEM tie-ups

Key Treatment for Gastroparesis Companies11 items

Janssen Global Services

Evoke Pharma

Cardinal Health

Salix Pharmaceuticals

Alfa Wassermann

Abbott Laboratories

Medtronic

C.R.Bard

Rhythm Pharmaceuticals

Boston Scientific

Kimberly-Clark

Market Ecosystem

Raw material/component suppliers — providing medical equipment

OEMs / manufacturers — producing treatment devices

Technology providers — developing diagnostic tools

System integrators / EPCs — integrating treatment systems

Distributors / channel partners — supplying treatment products

Service providers / after-sales — offering maintenance services

End users / buyers — receiving treatment for Gastroparesis

Recent Industry Insights

Analyst Overview

Table of Contents